Tyra Biosciences, Inc.

Cidara Therapeutics, Inc.

Daniel C Bensen

Robert L Hudkins

Allen Borchardt

Thanh To Lam

Wanlong Jiang

Quyen-Quyen Thuy Do

Thomas P Brady

Zhi-Yong Chen

Leslie W Tari

Jason Cole

James M Balkovec

Alain Noncovich

Simon Doehrmann

Disclosed herein are indazole compounds and methods of treating diseases and/or conditions (e.g., cancer) with the indazole compounds disclosed herein.

Indazole compounds

Disclosed herein are compounds and methods of treating diseases and/or conditions associated with FGFR inhibition.

Indazole compounds as kinase inhibitors

Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Compositions and methods for the treatment of viral infections

Growing community of inventors

Carlsbad, CA, United States of America

Daniel C Bensen